Abstract
Background
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic condition with various genetics and environmental influences that affects the capacity of the body to produce or use insulin resulting in hyperglycemia, which may lead to variable complications. It is one of the world’s rising health problems. There is emerging evidence that some genetic polymorphisms can impact the risk of evolving T2DM. We try to determine the relationship of (rs7903146) variant of the Transcription factor 7-like 2 (TCF7L2) gene with T2DM and its microvascular complications.
Methods and results
This case–control study included 180 subjects: 60 diabetic patients without complications, 60 diabetic patients with microvascular complications and 60 matched healthy controls. Genotypes of rs7903146 (C/T) SNP in the TCF7L2 gene were evaluated by real-time polymerase chain reaction via TaqMan allelic discrimination. Logistic regression was used to detect the most independent factor for development of diabetes and diabetic microvascular complications. Variant homozygous TT and heterozygous CT genotypes were significantly increased in diabetic without complications and diabetic with complications groups than controls (p = 0.003, 0.001) respectively. The T allele was more represented in both patient groups than controls with no significant difference between patient groups. TT genotype as well as T allele was significantly associated with increased T2DM risk.
Conclusion
The T allele of rs7903146 polymorphism of TCF7L2 confers susceptibility to development of T2DM. However, no significant association was found for diabetic complications.
Similar content being viewed by others
Data availability
The datasets generated analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- 2 h pp:
-
2 Hours Postprandial
- ACR:
-
Microalbumin/Creatinine Ratio
- DN:
-
Diabetic Nephropathy
- DR:
-
Diabetic Retinopathy
- GLP-1:
-
Glucagon-Like Peptide 1
- HbA1c:
-
Glycated Hemoglobin
- HDL-C:
-
High-Density Lipoprotein
- LDL-C:
-
Low-Density Lipoprotein
- T2DM:
-
Type 2 Diabetes Mellitus
- TCF7L2:
-
Transcription Factor 7-Like 2
- TG:
-
Triglycerides
References
De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti D (2018) Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne) 9:2
Du B, Jia X, Tian W, Yan X, Wang N, Cai D et al (2021) Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population. J Diabetes Complications 35(1):107752
Poznyak A, Grechko A, Poggio P, Myasoedova V, Alfieri V, Orekhov A (2020) The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci 21(5):1835
Emara M, El-Edel R, Fathy W, Aboelkhair N, Watany M, Abou-Elela D (2020) Study the association of tumor necrosis factor promoter polymorphism with type 2 diabetic nephropathy. Mediators Inflamm. https://doi.org/10.1155/2020/1498278
Mauricio D, Alonso N, Gratacòs M (2020) Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab 31(4):287–295
Dalhat M, Musa M (2018) Transcription factor 7 like 2 (TCF7L2) expression level variation contributes to VEGF alteration in diabetic retinopathy. Ophthalmol Res An Int J 8(1):1–7
Zaidi A, Abbas S, Singh SP, Raza ST, Mahdi F (2018) Role of Gstp, Tcf, Elmo1, Trpc 1, Il-10 gene polymorphism in diabetic nephropathy. Era’s J Med Res 5(2):170–174
Mandour I, Darwish R, Fayez R, Naguib M, El-Sayegh S (2018) TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus, a pilot study. Biomed Pharmacol J 11(2):1043–1049
Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O (2015) Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Glob Heal 81(6):814–820
Abbas S, Raza S, Mir S, Siddiqi Z, Zaidi A, Zaidi Z et al (2019) Association of variants rs7903146 and rs290487 of TCF7L2 gene with diabetic nephropathy and co-morbidities (hypertension and dyslipidemia) in type 2 diabetes mellitus. Meta Gene 20:100561. https://doi.org/10.1016/j.mgene.2019.100561
Wrzosek M, Sawicka A, Wrzosek M, Piątkiewicz P, Tałałaj M, Nowicka G (2019) Age at onset of obesity, transcription factor 7-like 2 (TCF7L2) rs7903146 polymorphism, adiponectin levels and the risk of type 2 diabetes in obese patients. Arch Med Sci 15(2):321–329
Biadgo B, Abebe S, Baynes H, Yesuf M, Alemu A, Abebe M (2017) Correlation between serum lipid profile with anthropometric and clinical variables in patients with type 2 diabetes mellitus. Ethiop J Health Sci 27(3):215–226
Bhattarai S, Godsland IF, Misra S, Johnston DG, Oliver N (2019) Metabolic health and vascular complications in type 1 diabetes. J Diabetes Complications 33(9):634–640
Chawla A, Chawla R, Jaggi S (2016) Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20(4):546–551
Mukherjee B, Shankar S, Ahmed R, Singh K, Bhatia K (2017) Association of glycated haemoglobin and serum apolipoproteins with diabetic retinopathy: an indian overview. J Clin Diagn Res 11(9):BC19–BC23
Saravani R, Irani Z, Galavi H (2016) Evaluation of transcription factor 7 like 2 polymorphisms and haplotypes in risk of Type 2 Diabetes. Rev Rom Med Lab 24(4):423–430
Alzahrani S, Baig M, Aashi M, Al-Shaibi F, Alqarni D, Bakhamees W (2019) Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study. Diabetes Metab Syndr Obes 12:1639–1644
Nanfa D, Sobngwi E, Atogho-Tiedeu B, Noubiap J, Donfack O, Mofo E et al (2015) Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study. Clin Transl Med 4(1):17
Demirsoy I, Aras N (2016) TCF7L2 rs7903146 gene variation is associated with risk of type 2 diabetes in Turkish population. J Clin Med Genom 4(1):2–4
Buraczynska M, Swatowski A, Markowska-Gosik D, Kuczmaszewska A, Ksiazek A (2011) Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract 93(3):390–395
Assmann T, Duarte G, Rheinheimer J, Cruz L, Canani L, Crispim D (2014) The TCF7L2 rs7903146 (C/T) polymorphism is associated with risk to type 2 diabetes mellitus in Southern-Brazil. Arq Bras Endocrinol Metabol 58(9):918–925
Wu L, Hsieh C, Pei D, Hung Y, Kuo S, Lin E (2009) Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARγ and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 24(11):3360–3366
Verma S, Srivastava N, Banerjee M (2016) PS 04-25 association Of TCF7L2 and PPARΓ gene variants with type 2 diabetes mellitus in North Indian population. J Hypertens 34:e139–e140
Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D’Amato C, Novelli G et al (2013) TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol 50(5):789–799
Dendup T, Feng X, Clingan S, Astell-Burt T (2018) Environmental risk factors for developing type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health MDPI 15(1):78
Jin T (2016) Current understanding on role of the Wnt signaling pathway effector TCF7L2 in glucose homeostasis. Endocr Rev 37(3):254–277
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
Conceptualization: NTA, RHE-E. Methodology: NTA, AAAE-M. Formal analysis and investigation: AAAE-M, HEK. Writing-original draft preparation: AAAE-M. Writing—review and editing: NTA. Funding acquisition: No fund. Supervision: RHE-E. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Consent to participate
Consent to participate was obtained from all individuals included in the study.
Consent to publish
Consent to publish relevant data was taken from all participants.
Ethical approval
This research was approved by the Research Ethics Committee at Menoufia Faculty of Medicine according to 1964 Helsinki declaration and informed consent was taken from every participant in the study. IRB approval number: 19919CPATH31.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aboelkhair, N.T., Kasem, H.E., Abdelmoaty, A.A. et al. TCF7L2 gene polymorphism as a risk for type 2 diabetes mellitus and diabetic microvascular complications. Mol Biol Rep 48, 5283–5290 (2021). https://doi.org/10.1007/s11033-021-06537-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06537-0